CAI
Clinical Asset Index
by VOS Supply Group
Drugs · acquisition-cost intelligence

Cyclogyl

cyclopentolate hydrochloride· ingredient cyclopentolate· CYCLOPENTOLATE HYDROCHLORIDE 10 mg/mL; CYCLOPENTOLATE HYDROCHLORIDE 20 mg/mL; CYCLOPENTOLATE HYDROCHLORIDE 5 mg/mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$2.47
NADAC — pharmacy acquisition cost, not a retail/cash price

Acquisition-cost history

Weekly NADAC per ML — the trend nobody else shows. 7 weeks.

2025-03-192026-05-20

Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.